2018 British Journal of Haematology, Toxicity Results
Study Purpose: The study investigated the safety and efficacy of TBL-12 in patients with ASMM.
TBL-12: This is a sea cucumber extract that has shown potential antitumor properties in previous research, including anti-angiogenesis, direct tumor cytotoxicity, and inhibition of osteoclastogenesis.
Participants: Twenty patients with ASMM participated in the study. These patients were characterized as being at high risk for disease progression based on established criteria.
Treatment: Patients ingested 2 units of 20 ml of TBL-12 twice per day, for a total of 80 ml per day.